Our website is a unique platform where students can share their papers in a matter of giving an example of the work to be done. If you find papers
matching your topic, you may use them only as an example of work. This is 100% legal. You may not submit downloaded papers as your own, that is cheating. Also you
should remember, that this work was alredy submitted once by a student who originally wrote it.
The paper "Hormone Replacement Therapy on Cardiovascular Events" highlights that the preceding analysis reveals certain weaknesses in the design of the study. It appears as though the researchers did not undertake a thorough review of existing literature prior to designing their study. …
Download full paperFile format: .doc, available for editing
Extract of sample "Hormone Replacement Therapy on Cardiovascular Events"
Article Analysis: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial Institution
Course
Date
Article Analysis: Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial
Introduction
This paper critically analyses an article by Schierbeck et al. titled Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. The article reports the findings of an empirical study that sought to examine how hormone replacement therapy affected cardiovascular outcomes, in the long term, among women that had recently reached menopause (Schierbeck, et al., 2012). The researchers justified the study on the basis of a knowledge gap that existed in the topic. Prior to their study, a few facts were known: several observational studies had consistently indicated that hormone replacement therapy (HRP) reduced the risk of coronary heart diseases in women. Randomised trials had shown a null effect, although the majority of women in the studies were aged over 60 and, therefore, over ten-year post menopause. Randomised HRT trials and meta-analyses indicated that when initiated in women aged below 60 or within ten years of menopause, HRT reduced the risk of CHD and total mortality(Schierbeck, et al., 2012). Thus, the study sought to add to the existing knowledge the effect of HRT on the incidence of CHD in women who had recently reached menopause. Had the study been designed to last over a shorter duration, the results would have been different.
The article under review is analysed under the following headings: methods of data collection and analysis, results, discussion and conclusion. In analysing the article, reference is made to five similar scholarly articles and how those articles approached the various sections. The author then concludes by summing up the article’s main strengths and limitations.
Analysis
Methods of Data Collection and Analysis
The study leading to the article being analysed was a part of the Danish Osteoporosis Prevention Study, a prospective study carried out at several centres and which sought to evaluate the prospects of HRT as a means of preventing osteoporotic fractures (Schierbeck, et al., 2012). The study was conducted between 1990 and 1993 and involved 2016 women. To be considered, a woman had to meet certain criteria: she had to be healthy, white, aged between 45 and 58, and experienced her last menstrual bleeding 3-24 months prior to participating in the study or premenopausal symptoms such as irregular menstruations. As an exception, women aged between 45 and 52 were included if they had had hysterectomy and had a history of their hormone levels being stimulated by serum follicle(Schierbeck, et al., 2012). A woman was excluded if she had: a history of bone disease, an uncontrolled chronic disease, past or ongoing treatment with glucocorticoids for over six months, suffered from cancer at any point in her life, undergone HRT within the three months leading to her participation in the study and drug or alcohol dependency. As can be seen, the study was highly controlled.
Of the 2016 women enrolled into the study, 1006 were randomly picked to receive HRT(Schierbeck, et al., 2012). Of these, 502 were placed under treatment while the remaining 506 received no treatment that is, they served as the control group. The remaining 1010 women had the choice of either undergoing HRT or not. The article being analysed reported only the results from the randomised groups. Upon entering the survey, each participant underwent physical examination and was screened biochemically. Each participant was then seen six months, one year and 2, 3, 5 and ten years after being recruited into the study. An individuals participation in the study ended with the occurrence of either of two events: death, or hospitalisation as a result of heart failure or myocardial infarction (Schierbeck, et al., 2012). The monitoring of participants ended on June 16, 2008 and data on all participants was retrieved from the Danish civil registration database and the national register of hospital discharge.
Data relating to the randomised participants were analysed from the onset of the study to the first day of August, 2002, almost a decade later. In order to capture the long term effects, secondary analyses were conducted for another six years until 2008 (Schierbeck, et al., 2012). Analyses were carried out using various techniques. Dichotomous variables were tested using a χ2 test while continuous variables were tested using the t test. P
Read
More
Share:
CHECK THESE SAMPLES OF Hormone Replacement Therapy on Cardiovascular Events
Testosterone or the hormone responsible for facial and body hair patterns, deep voice and muscle mass, gradually decreases after men reach the age of 30.... Workplace environment may encourage the onset of premature andropause brought by exposure to estrogen through excessive female hormone stimulation particularly in plastics and pharmaceutical factories, workplace near incinerators, and farms that use pesticides.... The causes of andropause are comprised not only by the decrease in testosterone but with the increase of the sex hormone binding globulin (SHBG) levels as well....
The European Society of Cardiology launched the Women at heart program in order to evaluate research initiatives on cardiovascular diseases for women.... Policy Conference on cardiovascular Diseases was an initial program developed for this program (Stramba-Badiale, et.... The paper "Treatment of cardiovascular Disease in Women" states that cardiovascular diseases are considered the major cause of mortality among men and women....
It is estimated that 50-70 million Americans have cardiovascular problems and according to Noonan (2005), cardiovascular events was responsible for the deaths of 260,000 American men in year 2000 alone.... The term 'cardiovascular Disease' has evolved over the years to subsume a wide array of meanings, ranging from the common definition to what it technically denotes.... Commonly, cardiovascular disease refers to the class of diseases that involve the heart and/or blood vessels (arteries and veins)....
The paper "Antibody-Mediated Hypersensitivity and Cell-Mediated Immunity" explains antibody-mediated hypersensitivity occurs whenever the antibodies become directed against the antigens along the surface of the tissue components and cells.... The deposition of antibodies might have detrimental effects....
Heart and Estrogen-Progestin Replacement Study (HERS) and Women's Estrogen for Stroke Trial (WEST) exhibited that cHRT and unopposed estrogen replacement therapy were ineffective for secondary prevention of cerebrospinal events in postmenopausal women (Hulley, 1998; Viscoli, 2001).... For instance, the WHI report affirms that 'estrogen therapy caused fewer cases of breast cancer but the data was not statistically significant'?... Both the ovaries begin to shrink and levels of estrogen and progesterone fluctuate as the ovaries strive to maintain the hormone production....
The treatment of low T in men is by use of a replacement testosterone therapy.... This paper "The Side Effects of Anabolic Steroids - Use, Abuse, Disease, and Condition" explores the pathophysiology of Low T and liver disease in humans.... The paper analyzes the causes, and physiological changes, which occur in, the progression of the diseases....
This report "Analysis of Pharmaceutical Issues" presents a pharmaceutical drug that is defined as a chemical substance that is used for the purposes of medical diagnosis, treatment, and prevention of diseases.... This definition is derived from the Greek word pharmacies.... ... ... ... A pharmaceutical drug is also defined as a substance that contains an active ingredient that is used for the treatment of certain diseases....
Treatment at end-stage renal failure is renal replacement therapy and regular follow-ups with a nephrologist.... .... ... ... The paper 'Clinical Biochemistry Findings in a Patient with End-Stage Renal Failure' is a potent version of the case study on health sciences & medicine.... End-stage renal disease is defined by a marked loss of kidney function....
8 Pages(2000 words)Case Study
sponsored ads
Save Your Time for More Important Things
Let us write or edit the essay on your topic
"Hormone Replacement Therapy on Cardiovascular Events"
with a personal 20% discount.